| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |